The Flow Diversion Aneurysm Market size to grow by USD 1.75 billion | Market Research Insights highlight The increasing prevalence of IAs and associated risk factors as Key Driver

According to the research report “Flow Diversion Aneurysm Treatment Market by Product and Geography – Forecast and Analysis 2021-2025“, the market will witness a YOY growth of 7.85% in 2021 at a CAGR of 8.26% during the forecast period. Furthermore, this report extensively covers market segmentation by product (FDS and intrasaccular flow disruption devices) and geography (North America, Europe, Asia, and ROW).

For more insights on YOY and CAGR, Read our FREE Sample Report

Latest market research report titled Flow Diversion Aneurysm Treatment Market has been announced by Technavio which is proudly partnering with Fortune 500 companies for over 16 years
Latest market research report titled Flow Diversion Aneurysm Treatment Market has been announced by Technavio which is proudly partnering with Fortune 500 companies for over 16 years

Vendor Insights 

The flow diversion aneurysm treatment market is concentrated and the vendors are deploying various organic and inorganic growth strategies to compete in the market. Owing to an increase in the prevalence of aortic and brain aneurysms and an increased desire for less invasive therapies the need for flow diversion aneurysm treatments is expected to rise during the forecast period. Vendors are primarily focusing on North America and Europe for the launch of new products.

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

  • Acandis GmbH 
  • Boston Scientific Corp. 
  • Cardinal Health Inc. 
  • Cook Group Inc. 
  • Johnson and Johnson Inc. 
  • Medtronic Plc 
  • MicroPort Scientific Corp. 
  • phenox GmbH 
  • Stryker Corp. 
  • Terumo Corp.

Find additional highlights on the growth strategies adopted by vendors and their product offerings, Read Free Sample Report. 

Geographical Market Analysis 

North America will provide maximum growth opportunities in the flow diversion aneurysm treatment market during the forecast period. According to our research report, the region will contribute 40% of the global market growth and is expected to dominate the market through 2025. 

The US and Canada are the key markets for flow diversion aneurysm treatment in North America. The market’s quick expansion in this region can be related to increased awareness about the effects of aneurysms and treatment methods, as well as an increase in the number of flow diversion surgeries performed, improved healthcare infrastructure, and increased healthcare spending.

The US is the major revenue generator in North America, followed by Canada. This is due to the high prevalence of IAs and an increase in the number of flow diversion and disruption procedures being performed. The launch of new products for the treatment of aneurysms is likely to drive the flow diversion aneurysm treatment market in North America during the forecast period.

Furthermore, countries such as North America, Europe, Asia, and ROW are expected to emerge as prominent markets for the flow diversion aneurysm treatment market during the forecast period. 

Know more about this market’s geographical distribution along with the detailed analysis of the top regions.

Key Segment Analysis

The flow diversion aneurysm treatment market share growth by the FDS segment has been significant. Flow-diverting stents (FDSs) are tubular, braided metallic stents placed in the parent artery across the aneurysm neck to decrease the blood flow into an intracranial aneurysm. FDSs are particularly used in the treatment of fusiform IAs, large and giant IAs, wide-necked IAs, etc. 

The major advantages of FDS are favorable long-term angiographic outcomes, including the absence of aneurysms recurrence after complete occlusion, avoidance of any intra-aneurysmal manipulation, and additional structural strength for the segment of the blood vessel from which an aneurysm originates. During the forecast period, product launches by vendors in the market are anticipated to increase the adoption of FDS for the treatment of a variety of aneurysms.  

View FREE Sample: to know additional highlights and key points on various market segments and their impact in coming years. 

Key Market Drivers & Trends: 

The increasing prevalence of IAs and associated risk factors is notably driving the flow diversion aneurysm treatment market growth. The risk of IAs significantly increases with age. According to the World Bank Group, 9.3 percent of the global population was 65 or older in 2020, and this percentage is likely to rise dramatically over the next few years. 

Other risk factors associated with IAs, such as hypertension, smoking, and excessive alcohol consumption, are also on the rise.  An increase in the number of people vulnerable to aneurysms is anticipated to drive the demand for flow diversion aneurysm treatment products during the forecast period.

Download free sample for highlights on market Drivers & Trends affecting the flow diversion aneurysm treatment market. 

Customize Your Report 

Don’t miss out on the opportunity to speak to our analyst and know more insights about this market report. Our analysts can also help you customize this report according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.  

We offer USD 1,000 worth of FREE customization at the time of purchase. Speak to our Analyst now! 

 Related Reports: 

Bile Duct Cancer Market by Type and Geography – Forecast and Analysis 2022-2026

Flow Diversion Aneurysm Treatment Market Scope
Report CoverageDetails
Page number120
Base year2020
Forecast period2021-2025
Growth momentum & CAGRAccelerate at a CAGR of 8.26%
Market growth 2021-2025$ 1.75 billion
Market structureConcentrated
YoY growth (%)7.85
Regional analysisNorth America, Europe, Asia, and ROW
Performing market contributionNorth America at 40%
Key consumer countriesUS, UK, Germany, Canada, and China
Competitive landscapeLeading companies, competitive strategies, consumer engagement scope
Companies profiledAcandis GmbH, Boston Scientific Corp., Cardinal Health Inc., Cook Group Inc., Johnson and Johnson Inc., Medtronic Plc, MicroPort Scientific Corp., phenox GmbH, Stryker Corp., and Terumo Corp.
Market DynamicsParent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,
Customization purviewIf our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

About Us: 

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. 


Technavio Research 
Jesse Maida 
Media & Marketing Executive 
US: +1 844 364 1100 
UK: +44 203 893 3200 
Email: [email protected] 

SOURCE Technavio

Leave a Reply

Your email address will not be published. Required fields are marked *